Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bader, Michael Prof. Dr. (14) Bähring, Sylvia Dr. (1) Birchmeier, Walter Prof. Dr. (7) Birchmeier-Kohler, Carmen Prof. Dr. (4) Blankenstein, Thomas Prof. Dr. (5) Daniel, Peter Prof. Dr. (4) Daumke, Oliver Prof. Dr. (2) Dechend, Ralf Priv. Doz. (7) Falk, Kirsten Dr. (1) Fielitz, Jens Dr. (1) Gorski, Stan Dr. (1) Gotthardt, Michael Prof. Dr. (1) Hammes-Lewin, Annette Dr. (2) Heinemann, Udo Prof. Dr. (2) Hinz, Michael Dr. (1) Hübner, Norbert Prof. Dr. (1) Jarosch, Ernst Dr. (1) Jentsch, Thomas Prof. Dr. (11) Kammertöns, Thomas Dr. (1) Kettenmann, Helmut Prof. Dr. (11) Kettritz, Ralph Prof. Dr. (5) Kirsch, Frank-Peter Dr. (1) Klußmann, Enno PD Dr. (5) Kühn, Ralf Dr. (4) Lee, Young-Ae Prof. Dr. (2) Lewin, Gary Prof. Dr. (4) Luft, Friedrich Prof. Dr. (64) Mathas, Stephan Dr. (1) Morano, Ingo Prof. Dr. (1) Müller, Dominik Prof. Dr. (11) Na, Il-Kang Dr. (1) Niendorf, Thoralf Prof. Dr. (2) Ohler, Uwe Prof. Dr. (2) Perrot, Andreas (5) Pischon, Tobias Prof. Dr. (6) Poulet, James Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Rathjen, Fritz Prof. Dr. (2) Rehm, Armin Dr. (1) Rosenthal, Walter Prof. Dr. (2) Saar, Kathrin Dr. (1) Sander, Maike Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (40) Schmitt, Clemens Prof. Dr. (2) Schreiber, Adrian PD Dr. med. (1) Schulz-Menger, Jeanette Prof. Dr. (4) Selbach, Matthias Prof. Dr. (3) Sommer, Thomas Prof. Dr. (1) Sperling, Silke Prof. Dr. (1) Stein, Ulrike Prof. Dr. (3) Waiczies, Sonia PD Dr. (1) Wallukat, Gerd Dr. (2) Walther, Wolfgang Prof. Dr. (3) Wanker, Erich Prof. Dr. (6) Willnow, Thomas Prof. Dr. (5) Wolf, Jana Prof. Dr. (1) (-) Gerhardt, Holger Prof. Dr. (1) (-) Leutz, Achim Prof. Dr. (5) (-) Scheidereit, Claus Prof. Dr. (7) AG Müller/Dechend (ECRC) (1) Biologie maligner Lymphome (1) Hypertonie-vermittelter Endorganschaden (1) Hypertonie bedingte Endorganschäden (1) Integrative Vaskuläre Biologie (1) 1992 (6) 1993 (5) 1994 (6) 1995 (3) 1996 (7) 1997 (9) 1998 (5) 1999 (12) (-) 2001 (13) 2002 (12) 2004 (15) 2005 (9) 2007 (10) 2008 (15) 2009 (14) 2010 (9) 2011 (18) 2013 (18) 2014 (18) 2015 (20) 2016 (18) 2017 (16) 2018 (16) 2019 (20) 2021 (21) 2022 (26) 2023 (17) 2024 (1) 13 Ergebnisse: Active Filter: Gerhardt, Holger Prof. Dr.Leutz, Achim Prof. Dr.Scheidereit, Claus Prof. Dr.2001 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2001 / Mol Cell Biol Shared pathways of IkappaB kinase-induced SCF betaTrCP-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and I kappa B alpha V. Heissmeyer D. Krappmann E.N. Hatada C. Scheidereit 01. Januar 2001 / Am J Hum Genet Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia S.A. Slaugenhaupt A. Blumenfeld S.P. Gill M. Leyne J. Mull M.P. Cuajungco C.B. Liebert B. Chadwick M. Idelson L. Reznik C.M. Robbins I. Makalowska M.J. Brownstein D. Krappmann C. Scheidereit C. Maayan F.B. Axelrod J.F. Gusella 01. Januar 2001 / Genes Dev Activation of the Notch-regulated transcription factor CBF1/RBP-J kappa through the 13SE1A oncoprotein S. Ansieau L.J. Strobl A. Leutz 01. Januar 2001 / Curr Opin Dev Chromatin remodeling in development and differentiation C. Mueller A. Leutz 01. Januar 2001 / Blood Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells M. Hinz P. Loeser S. Mathas D. Krappmann B. Dörken C. Scheidereit 01. Januar 2001 / Leukemia In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappaB activity C. Wuchter D. Krappmann Z. Cai V. Ruppert C. Scheidereit B. Doerken W.D. Ludwig L. Karawajew 01. Januar 2001 / FASEB J Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organ damage D.N. Mueller V. Heissmeyer R. Dechend F. Hampich J.K. Park A. Fiebeler E. Shagdarsuren J. Theuer M. Elger B. Pilz V. Breu K. Schroer D. Ganten R. Dietz H. Haller C. Scheidereit F.C. Luft 01. Januar 2001 / Mol Cell Biol B-cell receptor- and phorbol ester-induced NF-kappa B and c-Jun N-terminal kinase activation in B cells requires novel protein kinase C's D. Krappmann A. Patke V. Heissmeyer C. Scheidereit 01. Januar 2001 / Oncogene Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP M. Oelgeschlager E. Kowenz-Leutz S. Schreek A. Leutz B. Luescher 01. Januar 2001 / Development Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices R. Schmidt-Ullrich T. Aebischer J. Huelsken W. Birchmeier U. Klemm C. Scheidereit Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Januar 2001 / Mol Cell Biol Shared pathways of IkappaB kinase-induced SCF betaTrCP-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and I kappa B alpha V. Heissmeyer D. Krappmann E.N. Hatada C. Scheidereit
01. Januar 2001 / Am J Hum Genet Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia S.A. Slaugenhaupt A. Blumenfeld S.P. Gill M. Leyne J. Mull M.P. Cuajungco C.B. Liebert B. Chadwick M. Idelson L. Reznik C.M. Robbins I. Makalowska M.J. Brownstein D. Krappmann C. Scheidereit C. Maayan F.B. Axelrod J.F. Gusella
01. Januar 2001 / Genes Dev Activation of the Notch-regulated transcription factor CBF1/RBP-J kappa through the 13SE1A oncoprotein S. Ansieau L.J. Strobl A. Leutz
01. Januar 2001 / Curr Opin Dev Chromatin remodeling in development and differentiation C. Mueller A. Leutz
01. Januar 2001 / Blood Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells M. Hinz P. Loeser S. Mathas D. Krappmann B. Dörken C. Scheidereit
01. Januar 2001 / Leukemia In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappaB activity C. Wuchter D. Krappmann Z. Cai V. Ruppert C. Scheidereit B. Doerken W.D. Ludwig L. Karawajew
01. Januar 2001 / FASEB J Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organ damage D.N. Mueller V. Heissmeyer R. Dechend F. Hampich J.K. Park A. Fiebeler E. Shagdarsuren J. Theuer M. Elger B. Pilz V. Breu K. Schroer D. Ganten R. Dietz H. Haller C. Scheidereit F.C. Luft
01. Januar 2001 / Mol Cell Biol B-cell receptor- and phorbol ester-induced NF-kappa B and c-Jun N-terminal kinase activation in B cells requires novel protein kinase C's D. Krappmann A. Patke V. Heissmeyer C. Scheidereit
01. Januar 2001 / Oncogene Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP M. Oelgeschlager E. Kowenz-Leutz S. Schreek A. Leutz B. Luescher
01. Januar 2001 / Development Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices R. Schmidt-Ullrich T. Aebischer J. Huelsken W. Birchmeier U. Klemm C. Scheidereit